Table 3.

Non-infectious complications among PID patients

Non-infectiouscomplications	Total (N = 202)	XLA (n = 30)	CVID (n = 40)	HIgM (n = 21)	CGD (n = 20)	AT (n = 20)	LAD (n = 12)	HIES (n = 51)	HAE (n = 8)
Splenomegaly	29 (14.3)	1 (3.3)	14 (35.0)	3 (14.3)	8 (40.0)	1 (5.0)	2 (16.7)	0 (0.0)	0 (0.0)
Hepatomegaly	20 (9.9)	2 (6.7)	6 (15.0)	3 (14.3)	6 (30.0)	1 (5.0)	2 (16.7)	0 (0.0)	0 (0.0)
JRA	12 (5.9)	4 (13.3)	7 (17.5)	1 (4.8)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)
AIHA	7 (3.4)	1 (3.3)	6 (15.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)
ITP	8 (3.9)	1 (3.3)	5 (12.5)	0 (0.0)	1 (5.0)	1 (5.0)	0 (0.0)	0 (0.0)	0 (0.0)
Neutropenia	9 (4.4)	3 (10.0)	0 (0.0)	5(23.8)	0 (0.0)	0 (0.0)	0 (0.0)	1 (19)	1 (12.5)
Hypothyroidism	2 (0.9)	0 (0.0)	2(5.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)
Diabetes	1 (0.4)	0 (0.0)	0 (0.0)	1 (4.8)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)
Vitiligo	1 (0.4)	0 (0.0)	1 (2.5)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)
Alopecia	3 (1.4)	1 (3.3)	2(5.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)
Eczema	58 (28.7)	2 (6.7)	1 (2.5)	0 (0.0)	0 (0.0)	2 (10.0)	0 (0.0)	48 (94.1)	5 (62.5)
Clubbing	32 (15.8)	4 (13.3)	16 (40)	5(23.8)	3 (15)	1 (5)	0 (0.0)	3 (5.8)	0 (0.0)
Paralysis	2 (0.9)	2 (6.6)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)
Malignancy	3 (1.4)	0 (0.0)	2(5.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	1 (19)	0 (0.0)